## Neonatal Ophthalmia: Differential Diagnosis and Management ### Clinical Presentation Analysis **Key Point:** The timing, clinical features, and maternal history are crucial for differentiating causes of neonatal conjunctivitis. | Feature | Gonococcal | Chlamydial | Pseudomonas | Staphylococcal | | --- | --- | --- | --- | --- | | **Onset** | 2–5 days | 5–14 days (can be up to 6 weeks) | 5–7 days | 5–7 days | | **Discharge** | Profuse, purulent, blood-tinged | Copious, mucoid/purulent | Purulent, greenish | Mild to moderate, purulent | | **Conjunctival edema** | Severe (chemosis, lid swelling) | Mild to moderate | Moderate | Mild | | **Gram stain** | Intracellular gram-negative diplococci | No organisms (atypical) | Gram-negative rods | Gram-positive cocci | | **Corneal involvement** | Frequent (keratitis, scarring) | Rare | Frequent (keratitis, perforation) | Rare | | **Respiratory involvement** | Rare | Common (pneumonia 30–50%) | Rare | Rare | ### Why Chlamydial Ophthalmia Neonatorum? 1. **Timing:** 6 weeks of age fits the delayed presentation (5–14 days, sometimes up to 6 weeks) typical of *Chlamydia trachomatis*. 2. **Copious discharge:** Characteristic of chlamydial infection; gonococcal discharge is more hemorrhagic. 3. **Negative Gram stain:** *C. trachomatis* is an obligate intracellular pathogen and does not stain well with Gram stain. Gonococci appear as intracellular gram-negative diplococci. 4. **Maternal history:** Untreated maternal cervicitis is a risk factor for vertical transmission of *C. trachomatis*. 5. **No respiratory symptoms (yet):** Chlamydial pneumonia develops later (2–12 weeks), often after conjunctivitis resolves. **High-Yield:** Chlamydial ophthalmia neonatorum is the most common preventable cause of neonatal blindness in developing countries and the leading infectious cause of neonatal conjunctivitis in developed countries. ### Pathophysiology **Clinical Pearl:** *Chlamydia trachomatis* (serovars D–K) is transmitted during passage through an infected birth canal. The organism infects columnar epithelium of the conjunctiva, causing: - Acute follicular conjunctivitis (5–14 days) - Ascending infection → chlamydial pneumonia (2–12 weeks) in 30–50% of untreated cases - Chronic sequelae: pannus formation, trichiasis, symblepharon (rare if treated early) ### Treatment Regimens **Key Point:** Systemic therapy is essential because chlamydial infection is not limited to the eye; it involves the respiratory tract and gastrointestinal tract. **First-line options:** - **Azithromycin:** 10 mg/kg/day for 3 days (preferred in most guidelines) - **Erythromycin:** 12.5 mg/kg QID for 14 days (alternative; higher GI side effects) - **Topical erythromycin eye ointment alone is INSUFFICIENT** — does not treat systemic infection or prevent pneumonia **Why not other options?** - Fluoroquinolones (ciprofloxacin): Contraindicated in neonates due to risk of cartilage damage - Chloramphenicol: Risk of gray baby syndrome in neonates; not first-line - Ceftriaxone: Appropriate for gonococcal ophthalmia, not chlamydial ### Prevention **Mnemonic: PREVENT NEONATAL CHLAMYDIA** - **P**renatal screening of pregnant women - **R**efer for treatment if positive (azithromycin 1 g single dose) - **E**ye prophylaxis: Erythromycin 0.5% ointment at birth (prevents gonococcal and partially prevents chlamydial ophthalmia) - **V**ertical transmission prevention - **E**arly diagnosis and systemic treatment - **N**eonatal screening if maternal infection unknown - **T**reatment of partners to prevent reinfection ### Differential Diagnosis Exclusion ```mermaid flowchart TD A[Neonatal Conjunctivitis]:::outcome --> B{Age of onset?}:::decision B -->|2-5 days| C{Gram stain: GNDC?}:::decision B -->|5-14 days| D{Gram stain: GNDC?}:::decision C -->|Yes| E[Gonococcal ophthalmia]:::outcome C -->|No| F[Chlamydial or other]:::outcome D -->|Yes| G[Gonococcal ophthalmia]:::outcome D -->|No| H[Chlamydial ophthalmia]:::outcome E --> I[Ceftriaxone IV/IM]:::action H --> J[Azithromycin systemic]:::action ``` **Note:** GNDC = Gram-negative diplococci (intracellular)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.